May 7, 2018 TRANSPERS Contributes Two Paper to Health Affairs Theme Issue; Reported Today in Washington Post
April 17, 2018 TRANSPERS publication in JAMA lays out health policy agenda on new CMS coverage policy for sequencing tests in cancer patients
March 29, 2018 Study sheds light on short-term cost implications of integrating whole genome sequencing into clinical care
April 13, 2017 New TRANSPERS study teams up with leading experts to identify evidence gaps in genomic medicine that comparative effectiveness research can address
February 16, 2017 New TRANSPERS Study Identifies Opportunities to Resolving Reimbursement Challenges for Genetic Panel Tests for Cancer Risk Assessment
February 10, 2017 Value In Health features TRANSPERS papers and commentary on assessing the value of precision medicine and other Big Data technologies
October 18, 2016 New UCSF Center for Translational and Policy Research on Personalized Medicine (TRANSPERS) Study Examines Reasons for Rapid Insurance Coverage for Cell-Free DNA Prenatal Screening
June 13, 2016 TRANSPERS Collaborators Led by Deborah Marshall (University of Calgary) Publish in Genetics In Medicine
June 13, 2016 Kathryn publishes a chapter on “Personalized Medicine: Economic Evaluation and Evidence”
September 30, 2015 TRANSPERS Finds that Cost-Effectiveness of Most Clinically Actionable Genetic Findings that ACMG Recommends for Return Has Not Been Evaluated In Economic Studies
September 28, 2015 New TRANSPERS Publication in Nature Biotechnology Finds Dropping Prices and Lack of Payer Coverage for Multi-Gene Panels that include BRCA1/2
April 14, 2015 TRANSPERS Director Kathryn Phillips is working with the Patient-Centered Outcomes Research Institute (PCORI)